Highly concentrated liquid formulations of anti-EGFR antibodies

Details for Australian Patent Application No. 2005211890 (hide)

Owner Merck Patent GmbH

Inventors Matheus, Susanne; Mahler, HannsChristian

Agent Davies Collison Cave

Pub. Number AU-B-2005211890

PCT Pub. Number WO2005/077414

Priority 60/543,549 12.02.04 US

Filing date 27 January 2005

Wipo publication date 25 August 2005

Acceptance publication date 28 July 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/077414 Priority application(s): WO2005/077414

28 July 2011 Application Accepted

  Published as AU-B-2005211890

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005211896-Razor, and method for the production of such a razor

2005211876-Method and device for gasifying water